AI Compliance Checklist for Banking and Healthcare: What Regulators Expect in 2026

Regulated AI is no longer judged only by whether a model performs well. In banking and healthcare, compliance teams are expected to show how an AI system was built, what data shaped it, who approved it, how its decisions can be explained, and how it is monitored after deployment. This AI compliance checklist banking healthcare 2026 gives compliance and risk leaders a practical way to organize those expectations into evidence.

The checklist focuses on the controls regulators most commonly examine: governance, documentation, data quality, bias testing, explainability, human oversight, audit trails, security, and post-deployment monitoring. For high-risk AI systems, the EU AI Act expects a continuous risk-management process, representative data governance, technical documentation, logging, transparency, human oversight, accuracy, robustness, and cybersecurity.

Start With an AI Inventory

Know every AI system in use

Before assessing compliance, create a complete inventory of AI systems across the organization. Include internally built models, vendor platforms, embedded AI features in SaaS tools, generative AI applications, and AI-enabled medical devices or financial decision systems.

For each system, record:

• Business purpose and approved use case
• Business owner and model owner
• Vendor, model provider, or internal development team
• Model type and version
• Data sources and data lineage
• Deployment environment
• Countries and jurisdictions served
• Decision impact and automation level
• Human oversight design
• Risk classification
• Applicable regulations and internal policies
• Current compliance status

An inventory is the foundation of every other control. You cannot govern, test, document, or audit a system you have not identified.

Core AI Compliance Checklist

1. Governance and accountability

Checklist item	Evidence to maintain
Define an AI governance policy	Approved policy with scope, principles, roles, and escalation process
Assign an accountable executive or AI owner	Named owner in the AI inventory and approval record
Establish a governance committee or review board	Charter, membership, meeting minutes, and decision log
Classify AI systems by risk	Risk-tiering methodology and completed classification records
Define approval gates for high-risk systems	Intake form, risk assessment, and approval evidence
Maintain a RACI for AI lifecycle activities	RACI covering data, model, security, compliance, and business owners
Define vendor and third-party AI obligations	Vendor assessment, contract clauses, and ongoing monitoring records

Regulators expect clear accountability, not shared responsibility without a named decision-maker. Governance should connect AI risk management to existing model risk, privacy, security, clinical safety, and operational risk functions.

2. Risk management

Checklist item	Evidence to maintain
Identify intended purpose and prohibited uses	Use-case definition and acceptable-use policy
Identify affected individuals and potential harms	Impact assessment and stakeholder analysis
Assess privacy, security, fairness, safety, and operational risks	Risk register with likelihood, impact, and mitigations
Define risk appetite and acceptance criteria	Approved thresholds and escalation rules
Test controls before deployment	Pre-deployment validation and test results
Review risks throughout the lifecycle	Periodic risk reviews and updated risk register
Document residual risk decisions	Risk acceptance or mitigation approval record

The EU AI Act treats risk management as a continuous, iterative process across the AI lifecycle, with testing against predefined metrics and thresholds appropriate to the system’s intended purpose.

3. Data governance

Checklist item	Evidence to maintain
Document data sources and lineage	Source inventory, lineage map, and data-flow diagram
Confirm data relevance and representativeness	Dataset profile and representativeness assessment
Document training, validation, and test datasets	Dataset version, date range, source, and selection criteria
Identify sensitive, personal, or protected attributes	Data classification and privacy assessment
Validate data quality	Completeness, validity, accuracy, and freshness checks
Manage consent, lawful basis, and retention	Privacy impact assessment and retention schedule
Control data access	Role-based access matrix and access-review evidence
Document known data limitations	Data limitations register and mitigation plan

Healthcare regulators emphasize data management as a means of identifying and mitigating bias, while high-risk AI requirements call for relevant, representative, and sufficiently complete training, validation, and testing datasets.

4. Bias testing and fairness

Checklist item	Evidence to maintain
Identify protected attributes and proxies	Protected-attribute inventory and proxy analysis
Define fairness metrics for the use case	Approved fairness-testing plan
Test outcomes across relevant groups	Segment-level performance and outcome analysis
Measure error rates, approval rates, and disparities	Fairness audit report
Investigate root causes of disparities	Bias investigation and root-cause documentation
Apply and document mitigations	Mitigation options, decisions, and trade-offs
Retest after retraining or feature changes	Post-change fairness validation
Monitor fairness in production	Ongoing fairness dashboard and alert thresholds

Bias testing should not be a one-time exercise. Regulators and auditors increasingly expect evidence that organizations test for disparate impact, monitor outcomes over time, and document remediation efforts.

5. Explainability and transparency

Checklist item	Evidence to maintain
Explain the system’s intended purpose	Model card or system documentation
Explain major factors behind decisions	Reason codes, feature attributions, or decision rationale
Provide user-facing limitations and instructions	Instructions for use and user guidance
Explain confidence, uncertainty, or limitations	Confidence thresholds and known-limitation disclosure
Enable affected individuals to understand outcomes	Customer- or patient-facing explanation template
Ensure explanations match actual model behavior	Explanation validation evidence
Maintain version-specific explanations	Explanation documentation linked to model version

In financial services, organizations must be able to explain how an AI contributed to a decision, prove that the explanation is accurate, and show that a governed process was followed.

6. Human oversight

Checklist item	Evidence to maintain
Define when human review is required	Oversight policy and decision-routing rules
Assign qualified reviewers	Training records and role definitions
Give reviewers enough context to challenge AI output	Review interface, explanation access, and supporting evidence
Allow reviewers to override or stop the system	Override logs and safe-stop procedure
Monitor automation bias	Override rates, reviewer behavior, and quality checks
Document human decisions and exceptions	Review logs and exception register

Meaningful oversight requires more than a person clicking “approve.” Reviewers need adequate information, authority, time, and the ability to challenge or override the AI system.

7. Audit trail and traceability

Checklist item	Evidence to maintain
Log model version and configuration	Model registry and version history
Log input data, outputs, and key decisions	Decision logs with timestamps and identifiers
Log data sources and retrieval context	Data lineage and retrieval-source records
Log human overrides and reviewer identity	Oversight and exception logs
Log access to models and sensitive data	Access logs and audit records
Preserve logs for the required retention period	Retention policy and storage evidence
Enable reconstruction of a past decision	End-to-end traceability test result
Protect logs from tampering	Integrity controls and access restrictions

A strong audit trail should allow the organization to reconstruct which model version, configuration, data sources, prompts, and human actions produced a particular output or decision.

8. Performance, robustness, and security

Checklist item	Evidence to maintain
Define performance metrics and thresholds	Model evaluation plan and approved thresholds
Validate performance before deployment	Validation report and test results
Test edge cases and failure modes	Stress, adversarial, and scenario-testing evidence
Monitor accuracy, calibration, and error rates	Performance dashboard and alert history
Detect data and concept drift	Drift-monitoring reports
Define retraining and rollback criteria	Model lifecycle policy and change-control records
Protect models and data from unauthorized access	Security controls, penetration tests, and access reviews
Maintain incident response procedures	AI incident playbook and post-incident review

The EU AI Act links high-risk AI compliance to accuracy, robustness, cybersecurity, and lifecycle risk management.

Banking-Specific Checklist

Credit, lending, and underwriting

Requirement	Compliance evidence
Explain credit decisions and adverse outcomes	Reason codes, adverse-action explanations, and decision records
Test for disparate impact	Fairness audit across protected and proxy groups
Validate model performance independently	Model validation report and challenger-model results
Monitor model drift and economic shifts	Performance, stability, and drift-monitoring reports
Maintain model documentation	Model development, validation, and approval documentation
Preserve decision and override history	Audit trail with model version and reviewer identity
Review third-party AI vendors	Vendor due diligence and contractual controls

Banks should be able to explain how AI contributed to credit scoring, fraud detection, or advisory decisions, and demonstrate that the explanation is accurate and governed.

Fraud, AML, and financial crime

Requirement	Compliance evidence
Document alert logic and risk factors	Model documentation and feature definitions
Test false-positive and false-negative rates	Validation and threshold-testing results
Monitor changes in fraud or laundering patterns	Drift and alert-quality monitoring
Preserve investigation history	Case-management and investigator-action logs
Support regulatory inquiries	Traceable decision and alert records
Control access to sensitive investigation data	Access controls and audit logs

Healthcare-Specific Checklist

Clinical decision support and diagnostics

Requirement	Compliance evidence
Define intended clinical use and contraindications	Intended-use statement and clinical claim documentation
Validate performance on representative populations	Clinical validation study and subgroup analysis
Test performance across sites, devices, and demographics	External validation and robustness testing
Provide clinician-facing explanations	Evidence sources, confidence ranges, and rationale
Maintain human oversight	Clinician-review workflow and override records
Monitor real-world performance and drift	Post-market performance and drift-monitoring plan
Manage model updates safely	Change-control, validation, and deployment records
Protect patient data	Privacy assessment, access controls, and audit logs

The FDA has highlighted transparency and data management as important elements for identifying and mitigating bias in AI-enabled device software functions. It has also emphasized the need to evaluate real-world performance as data drift, concept drift, or model drift can reduce reliability or introduce bias.

Banking and Healthcare: Key Differences

Area	Banking	Healthcare
Primary concern	Fair lending, financial crime, consumer harm, model risk	Patient safety, clinical validity, privacy, care quality
Explainability focus	Reason codes, adverse-action rationale, auditability	Clinical rationale, evidence, uncertainty, clinician context
Bias focus	Protected classes, lending outcomes, fraud false positives	Demographics, sites, devices, clinical subpopulations
Oversight focus	Reviewer authority, override, escalation	Clinician judgment, safety escalation, clinical governance
Monitoring focus	Drift, performance, fraud-pattern changes	Real-world performance, drift, subgroup variation
Documentation focus	Model risk management and decision traceability	Clinical validation, intended use, safety, and traceability

Audit-Trail Flow

A regulator-ready audit trail should connect the full decision path:

text

Data source

   ↓

Data ingestion and validation

   ↓

Feature creation and versioning

   ↓

Model version and configuration

   ↓

Prediction or recommendation

   ↓

Explanation and confidence level

   ↓

Human review, override, or approval

   ↓

Business action and outcome

   ↓

Monitoring, incident, and retraining record

Each stage should retain:

• Timestamp
• User or system identity
• Data or model version
• Input and output reference
• Decision rationale or explanation
• Approval, override, or exception record
• Links to supporting evidence

This makes it possible to answer the central audit question: Why did the system make this decision, and can the organization prove it?

90-Day Compliance Readiness Plan

Period	Focus	Key actions
Days 1–30	Inventory and classify	Build AI inventory, assign owners, classify risk, identify applicable regulations
Days 31–60	Test and document	Complete data governance, bias testing, explainability review, and documentation for priority systems
Days 61–90	Monitor and evidence	Implement monitoring, audit trails, oversight workflows, incident response, and audit-readiness review

Start with one or two high-impact systems rather than attempting to remediate every AI application at once. Use the pilot to establish reusable templates, evidence standards, and governance workflows.

Conclusion:

Compliance readiness in 2026 depends on evidence, not declarations. Organizations that maintain an accurate AI inventory, test for bias, explain decisions, preserve audit trails, and monitor production behavior will be better prepared for regulatory scrutiny in both banking and healthcare.

FAQs

1. What should an AI compliance checklist banking healthcare 2026 include?

It should include AI inventory, governance and accountability, risk management, data governance, bias testing, explainability, human oversight, audit trails, security, performance monitoring, and vendor controls.

2. What documentation do regulators commonly expect?

Regulators commonly expect technical documentation, data lineage, model cards, risk assessments, validation results, fairness audits, decision logs, human-oversight records, monitoring evidence, and model version history.

3. How often should AI systems be tested for bias?

Test before deployment and retest after material changes such as retraining, new data sources, new features, or a change in population. High-risk systems should also have ongoing production monitoring for fairness and outcome disparities.

4. What is an AI audit trail?

An AI audit trail is a traceable record of the data, model version, configuration, inputs, outputs, explanations, human actions, and outcomes behind an AI-influenced decision. It should allow an auditor to reconstruct why a decision occurred.

5. Do banks need explainable AI for credit decisions?

Yes. Where AI contributes to credit scoring, fraud detection, or advisory decisions, the institution should be able to explain the decision, validate the explanation, and demonstrate that a governed process was followed.

6. What do healthcare regulators expect for AI-enabled medical devices?

Healthcare regulators expect transparency, data management to identify and mitigate bias, clinical validation, real-world performance monitoring, human oversight, and controls for drift or performance degradation.

7. Is human approval enough for AI compliance?

No. Human approval must be meaningful. Reviewers need relevant context, model limitations, explanation access, authority to challenge the output, and the ability to override or stop the system safely.